Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Merck to acquire coronavirus vaccine candidate developer Themis Bioscience Merck acquisition of Themis Bioscience : Merck has signed a deal to acquire Themis Bioscience, an Austrian vaccine… bypharmanewsdailyMay 27, 2020
